Skip to main content
Clinical Trials/NCT02226328
NCT02226328
Unknown
Phase 4

Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety.

Copenhagen University Hospital at Herlev1 site in 1 country128 target enrollmentNovember 2014

Overview

Phase
Phase 4
Intervention
Propofol sedation
Conditions
Flexible Bronchoscopy
Sponsor
Copenhagen University Hospital at Herlev
Enrollment
128
Locations
1
Primary Endpoint
Satisfaction with sedation
Last Updated
10 years ago

Overview

Brief Summary

Flexible bronchoscopy almost always requires sedation to be successful. In order to increase the availability of propofol for sedation, non-anaesthesiologist administered propofol sedation has been suggested as an alternative to traditional midazolam/opioid sedation or the general anaesthesia provided by anaesthesiologists.

Hypothesis: Patients undergoing flexible bronchoscopy prefers non-anaesthesiologist administered sedation with propofol as opposed to non-anaesthesiologist administered sedation with midazolam and fentanyl.

Propofol sedation is as safe as midazolam and fentanyl sedation.

Registry
clinicaltrials.gov
Start Date
November 2014
End Date
April 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Copenhagen University Hospital at Herlev
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Elective flexible bronchoscopy.
  • Willing to be randomised
  • Provide written informed consent

Exclusion Criteria

  • Allergy to contents administered
  • pregnant or nursing
  • \<18 years of age
  • Not able to complete questionnaire
  • Acute condition
  • severe COPD
  • Sleep apnea
  • Risk of aspiration
  • Previously difficulty with anesthesia
  • Difficult airway

Arms & Interventions

Propofol sedation

Refract bolus propofol sedation as monotherapy administered by a sedation-trained nurse endoscopist. Induction with 10-60 mg bolus, repeated every 45-60 sec. until moderate sedation. Maintenance with 10-20 mg of propofol in case of discomfort.

Intervention: Propofol sedation

Midazolam and Fentanyl sedation

1-2 mg of Midazolam with 0.025-0.05 mg of fentanyl for induction 10 prior to procedure initiation. Maintenance with 1 mg Midazolam in case of discomfort.

Intervention: Midazolam and Fentanyl sedation

Outcomes

Primary Outcomes

Satisfaction with sedation

Time Frame: At discharge, on average 30 minutes after procedure termination.

The average duration of bronchoscopy is estimated to 20 minutes. A validated satisfaction questionnaire will be filled by the patient at discharge from the recovery room, on average 30 minutes after completed procedure. Readiness for discharge will be assessed using an Aldrete score.

Secondary Outcomes

  • Number of adverse events as a surrogate marker of safety.(During procedure. On average 20 minutes.)

Study Sites (1)

Loading locations...

Similar Trials